Autolus Therapeutics plc

US$1.28As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AUTLHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (30.50%)
Div yield —
ROE (133.00%)
Biotechnology
Beta (5Y) 2.35
PE TTM —
TSR TTM (17.42%)
Mkt cap US$340.7M
ROIC (28.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.22
(4.30%)
(77.96%)
Hold 1|9|4|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
16.11%
28.37%
25.42%
33.04%
Revenue$M
18.57
18.39
18.06
18.82
8.77%
7.58%
4.82%
4.03%
Peers (US$340.7M)
Cap (US$)
PE
393.9M
203.0x
352.4M
—
340.9M
6.177x
Capital
TTM
5Y
10Y
Leveragex
14.15
0.047
0.056
EBIT/Intx
0.582
0.282
0.283
Own earn%
228.81
50.13
33.41
Sh yield%
10.27
52.26
48.43
Owners
Insiders/Inst%
7.03
68.54
Short interest%
5.75
SBC / revenue%
3.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
14–18
$1 testx
—
Incr. ROIC%
14